4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-21-060957
CEO sold 2,963 shares at $17.41 ($51,586)
- CEO acquired 5,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2021-10-15 | Option exercise | +5,938 | 55,869 | D | ||
| DAVIS STEPHEN CEO | 2021-10-18 | Sale | −2,963 | $17.41 | $51,586 | 52,906 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2021-10-15 | Option exercise · Restricted Stock Units | −5,938 | 5,938 | D | ||
| Open-market sales · 2,963 sh · avg $17.41 · $51,586 | |||||||
Loading xslF345X03/doc4.xml…